Changzhou Qianhong Biopharma (002550.SZ) Earnings Analysis

Changzhou Qianhong Biopharma (002550.SZ) has no confirmed upcoming earnings date. Trailing P/E 26.04.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 002550.SZ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 002550.SZ. This page updates as the calendar is published.

002550.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-10-300.1022 CNYn/an/an/a
2025-04-180.03684 CNYn/an/an/a
2025-03-310.1288 CNYn/an/an/a
2024-10-170.1015 CNYn/an/an/a
2024-08-150.06296 CNYn/an/an/a

002550.SZ valuation and analyst view

Trailing P/E26.04
Trailing EPS0.25738 CNY
Price / book2.97
Dividend yield2.22%
Market cap8.18B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Changzhou Qianhong Biopharma (002550.SZ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 002550.SZ. This page updates as the calendar is published.

Did 002550.SZ beat earnings last quarter?

Consensus estimate data was not available for 002550.SZ's 2025-10-30 report.

What is 002550.SZ's current P/E ratio and EPS?

002550.SZ trades at a trailing P/E of 26.04 on trailing EPS of 0.2573793146440558 CNY.

What do analysts rate 002550.SZ?

002550.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.